Blood-testing equipment maker Immucor says it agreed to be acquired by TPG Capital in a deal worth $1.97 billion, or $27 per share in cash.
Immucor to be bought for $1.97 billion
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.